This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Monday's Top 10 Articles, Videos on TheStreet

Stocks in this article: AAPL JPM CVX THRX EBAY

NEW YORK ( TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.

Stocks mentioned include: AAPL, JPM, CVX, THRX and EBAY

Analysts' Actions: JCP, BRCM, AAPL, P, BA
RealMoney Staff
Here are today's top research calls.

Apple's Share-Price Target Boosted by Goldman
Chris Ciaccia
Goldman Sachs raises Apple's price target going into earnings later this month on strong iPhone sales.

5 Rocket Stocks That Could Rally
Jonas Elmerraji
These stocks have both short-term gain catalysts and longer-term growth potential. (Stocks include: JPM, EBAY, V)

Gold Prices: Where Will They Finish 2012?
Alix Steel
Gold price had a wild and crazy ride in 2011. Will gold be able to reach new records in 2012?

Stocks Fall as Investors Eye Europe, Earnings
Chao Deng
Stocks waver as investors brace for earnings from Alcoa and react to the latest euro talks.

The Two Most Important Company Earnings This Week
Robert Holmes
JPMorgan will be the first bank out with results Friday, while Chevron will offer an update Wednesday.

9 Rich-Kid Stocks Bucking the Terrible Economy
Frank Byrt
Take advantage of the wealthy and maybe become one of them with these investments.

Stocks Set to Post Gain in 2012, History Shows
Lindsey Bell
A theory says the S&P 500 will rise in the year if it increases in the first five days of January.

Take a Look at the New Ford Fusion
Ted Reed
Ford's new Fusion will compete on design in the brutally competitive midsized car sector.

Theravance Shares Slide on Lung Drug Deaths
Adam Feuerstein
Theravance and partner Glaxo will seek Relovair approvals but data raise safety and efficacy questions.

This article was written by a staff member of TheStreet.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs